Keith Bonham

1.4k total citations
39 papers, 1.2k citations indexed

About

Keith Bonham is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis and Nutrition and Dietetics. According to data from OpenAlex, Keith Bonham has authored 39 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 8 papers in Health, Toxicology and Mutagenesis and 8 papers in Nutrition and Dietetics. Recurrent topics in Keith Bonham's work include Histone Deacetylase Inhibitors Research (9 papers), Trace Elements in Health (8 papers) and Ubiquitin and proteasome pathways (8 papers). Keith Bonham is often cited by papers focused on Histone Deacetylase Inhibitors Research (9 papers), Trace Elements in Health (8 papers) and Ubiquitin and proteasome pathways (8 papers). Keith Bonham collaborates with scholars based in Canada, United States and Sweden. Keith Bonham's co-authors include Lashitew Gedamu, Scott M. Dehm, Muhammad Zafarullah, Shawn Ritchie, Calley Hirsch, Daishi Fujita, Rajendra K. Sharma, Jason W.H. Wong, Carl Haux and Åke Larsson and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Keith Bonham

39 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Keith Bonham Canada 22 662 298 281 208 111 39 1.2k
Koki Kabu Japan 11 363 0.5× 145 0.5× 391 1.4× 138 0.7× 75 0.7× 22 1.1k
Nurten Saydam United States 16 648 1.0× 221 0.7× 274 1.0× 107 0.5× 271 2.4× 26 1.1k
J S Lazo United States 13 322 0.5× 200 0.7× 326 1.2× 171 0.8× 65 0.6× 19 789
Iih‐Nan Chou United States 17 513 0.8× 130 0.4× 103 0.4× 75 0.4× 134 1.2× 31 906
Anthony Lemarié France 18 771 1.2× 303 1.0× 118 0.4× 211 1.0× 346 3.1× 26 1.4k
Kenneth C. Palmer United States 18 437 0.7× 144 0.5× 64 0.2× 153 0.7× 123 1.1× 32 1.1k
Vasiliki Lalioti Spain 17 417 0.6× 66 0.2× 145 0.5× 138 0.7× 36 0.3× 36 748
Madeleine C. Brady United Kingdom 11 574 0.9× 167 0.6× 43 0.2× 198 1.0× 84 0.8× 14 955
Yaeko Nakajima‐Takagi Japan 18 1.2k 1.7× 83 0.3× 71 0.3× 84 0.4× 105 0.9× 41 1.5k
Johan Lund Sweden 20 494 0.7× 135 0.5× 45 0.2× 92 0.4× 103 0.9× 41 1.1k

Countries citing papers authored by Keith Bonham

Since Specialization
Citations

This map shows the geographic impact of Keith Bonham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keith Bonham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keith Bonham more than expected).

Fields of papers citing papers by Keith Bonham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Keith Bonham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keith Bonham. The network helps show where Keith Bonham may publish in the future.

Co-authorship network of co-authors of Keith Bonham

This figure shows the co-authorship network connecting the top 25 collaborators of Keith Bonham. A scholar is included among the top collaborators of Keith Bonham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keith Bonham. Keith Bonham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kirzinger, Morgan, Frederick S. Vizeacoumar, Cristina González‐López, et al.. (2019). Humanized yeast genetic interaction mapping predicts synthetic lethal interactions of FBXW7 in breast cancer. BMC Medical Genomics. 12(1). 112–112. 7 indexed citations
2.
Miah, Sayem, et al.. (2014). BRK Targets Dok1 for Ubiquitin-Mediated Proteasomal Degradation to Promote Cell Proliferation and Migration. PLoS ONE. 9(2). e87684–e87684. 16 indexed citations
3.
Hirsch, Calley, et al.. (2010). Histone deacetylase inhibitors mediate post-transcriptional regulation of p21WAF1 through novel cis-acting elements in the 3′ untranslated region. Biochemical and Biophysical Research Communications. 402(4). 687–692. 4 indexed citations
4.
Shrivastav, Anuraag, Shao H. Yang, Shawn Ritchie, et al.. (2008). Requirement of N-Myristoyltransferase 1 in the Development of Monocytic Lineage. The Journal of Immunology. 180(2). 1019–1028. 29 indexed citations
5.
Bonham, Keith, et al.. (2008). Histone acetylation is not an accurate predictor of gene expression following treatment with histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 367(3). 656–662. 17 indexed citations
6.
Saxena, Anurag, et al.. (2007). Short nucleotide polymorphic insertions in the MCL-1 promoter affect gene expression. Cancer Letters. 251(1). 114–131. 8 indexed citations
7.
Dehm, Scott M., et al.. (2006). The modification of Sp3 isoforms by SUMOylation has differential effects on the SRC1A promoter. Gene. 379. 68–78. 7 indexed citations
8.
Selvakumar, Ponniah, et al.. (2006). N‐Myristoyltransferase 2 expression in human colon cancer: Cross‐talk between the calpain and caspase system. FEBS Letters. 580(8). 2021–2026. 23 indexed citations
9.
Hirsch, Calley, et al.. (2005). Src family kinase members have a common response to histone deacetylase inhibitors in human colon cancer cells. International Journal of Cancer. 118(3). 547–554. 23 indexed citations
10.
Dehm, Scott M. & Keith Bonham. (2004). Regulation of alternative SRC promoter usage in HepG2 hepatocellular carcinoma cells. Gene. 337. 141–150. 1 indexed citations
11.
Selvakumar, Ponniah, et al.. (2004). Expression of methionine aminopeptidase 2, N-myristoyltransferase, and N-myristoyltransferase inhibitor protein 71 in HT29. Biochemical and Biophysical Research Communications. 322(3). 1012–1017. 19 indexed citations
12.
Dehm, Scott M., et al.. (2001). SRC transcriptional activation in a subset of human colon cancer cell lines. FEBS Letters. 487(3). 367–371. 44 indexed citations
13.
Chen, Zhuang, Scott M. Dehm, Keith Bonham, et al.. (2001). DNA Array and Biological Characterization of the Impact of the Maturation Status of Mouse Dendritic Cells on Their Phenotype and Antitumor Vaccination Efficacy. Cellular Immunology. 214(1). 60–71. 36 indexed citations
14.
Bonham, Keith, et al.. (2000). An Alternative, Human SRC Promoter and Its Regulation by Hepatic Nuclear Factor-1α. Journal of Biological Chemistry. 275(48). 37604–37611. 37 indexed citations
15.
Ritchie, Stephen M. & Keith Bonham. (1998). The Human c-Src Proto-oncogene Promoter Contains Multiple Targets for Triplex-Forming Oligonucleotides. Antisense and Nucleic Acid Drug Development. 8(5). 391–400. 4 indexed citations
16.
Finch, Joanne S., Keith Bonham, Peter Krieg, & G. Tim Bowden. (1990). Murine polyubiquitin mRNA sequence. Nucleic Acids Research. 18(7). 1907–1907. 21 indexed citations
17.
Olsson, Per‐Erik, Åke Larsson, Amund Maage, et al.. (1989). Induction of metallothionein synthesis in rainbow trout,Salmo gairdneri, during long-term exposure to waterborne cadmium. Fish Physiology and Biochemistry. 6(4). 221–229. 66 indexed citations
18.
Bonham, Keith, et al.. (1989). Activation of the cellular harvey ras gene in mouse skin tumors initiated with urethane. Molecular Carcinogenesis. 2(1). 34–39. 24 indexed citations
19.
Bonham, Keith, Muhammad Zafarullah, & Lashitew Gedamu. (1987). The Rainbow Trout Metallothioneins: Molecular Cloning and Characterization of Two Distinct cDNA Sequences. DNA. 6(6). 519–528. 108 indexed citations
20.
Bonham, Keith, et al.. (1986). Heavy metal-induced gene expression in fish and fish cell lines.. Environmental Health Perspectives. 65. 141–147. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026